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Abstract
Diabetic retinopathy (DR) is a common eye disease and a leading cause of visual impairment in 
patients with Type 1 diabetes (T1DM). Retinopathy screening for T1DM varies according to the age 
of disease onset and diabetes duration. Retinal screening varies from standard fundal examination 
to more advanced methods of screening. An online survey was conducted in February 2014. The 
purpose of this survey was to assess the frequency and methods of eye examinations routinely 
performed in children and adolescents with T1DM. Data on local practices were collected from 
a group of optometrists and ophthalmologists in the London-Middlesex area. One hundred and 
one surveys were e-mailed out and the response rate was 37.6%. Results indicated that different 
screening methods vary according to individual practices. These results may have an impact on the 
findings of retinopathy in this population. A review of utilized screening methods and comparisons 
to established guidelines will be highlighted.
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Résumé
La rétinopathie diabétique est une maladie oculaire répandue et une cause importante de déficience 
visuelle chez les personnes atteintes de diabète de type 1. Son dépistage varie suivant l’âge du patient 
quand le diabète est diagnostiqué et l’ancienneté de cette maladie. Les méthodes de dépistage 
vont du simple examen du fond d’œil à des techniques plus poussées. En février 2014, nous avons 
mené un sondage en ligne, afin d’évaluer la fréquence et la nature des examens oculaires menés 
systématiquement chez les enfants et les adolescents atteints de diabète de type 1. Les données sur 
les pratiques locales ont été recueillies chez des optométristes et des ophtalmologistes de la région de 
London-Middlesex (Ontario). Le taux de réponse aux 101 formulaires envoyés par courriel s’est établi 
à 37,6 %. Les résultats obtenus témoignent de la diversité des méthodes de dépistage appliquées par 
les praticiens. Cette diversité pourrait avoir une incidence sur le diagnostic de la rétinopathie chez les 
enfants et les adolescents diabétiques. Cet article expose les méthodes de dépistage appliquées, en les 
mettant en parallèle avec les méthodes recommandées dans les lignes directrices établies.
Mots clés : rétinopathie diabétique; diabète de type 1; enfants; complications microvasculaires.
Introduction 
In 2008/09, more than 3,000 new cases of diabetes (Type 1 and 
Type 2) were reported among Canadian children and youth 
aged one to 19 years, bringing the number of prevalent cases 
to just fewer than 26,000.  The rate of T1DM diabetes among 
one to nine year olds has increased, from 0.1% (3,726 cases) in 
1998/99 to 0.2% (5,201 cases) in 2008/09.1  Despite the increase 
in incidence, the prevalence of diabetic retinopathy (DR) has 
decreased globally, which is mainly attributed to improved 
management of diabetes  control.2  In a 20-year Australian 
study of 1604 adolescents with T1DM, it was found that the 
prevalence of DR was approximately 50% in the early 1990s, 
and decreased to approximately 12% in 2009.3 
The Diabetes Control and Complications Trial (DCCT, 
1983-1993)4 provided unequivocal evidence that intensive 
diabetes treatment and improved glycemic control conferred 
a significant risk reduction for microvascular complications 
compared with conventional treatment. In the adolescent 
cohort, intensive treatment compared with conventional 
treatment reduced the risk and progression of background 
retinopathy by 53 %.4 Diabetic retinopathy rarely develops 
in children with Type 1 diabetes <10 years of age regardless 
of the duration of diabetes. Among patients <15 years of age, 
irrespective of age of diabetes onset, the prevalence of mild 
nonproliferative retinopathy was 2% with no reported sight-
threatening diabetic retinopathy.2  However, the prevalence 
rate increases sharply after 5 years’ duration of diabetes in post 
pubertal individuals with Type 1 diabetes.2  Early identification 
and treatment of DR can decrease the risk of vision loss in 
affected patients. Therefore, it is imperative to screen for early 
signs of this complication in the pediatric T1DM population.
There are three distinct forms of DR: i) macular edema, 
ii) nonproliferative and proliferative DR, and iii) retinal 
capillary closure. Macular edema involves focal or diffuse 
vascular leakage at the site of the macula. Nonproliferative DR 
is the progressive accumulation of blood vessel change that 
includes microaneurysms, intraretinal hemorrhage, vascular 
tortuosity and vascular malformation (together known as 
nonproliferative diabetic retinopathy) that ultimately leads to 
abnormal vessel growth (proliferative diabetic retinopathy). 
Retinal capillary closure is a form of vascular change detected 
on fluorescein angiography, which is also well recognized as 
a potentially blinding complication of diabetes but currently 
has no treatment options.5 Severe nonproliferative DR, 
proliferative DR, and clinically significant macular edema are 
considered sight-threatening DR.
The aim of this survey was to explore the practices for DR 
screening in patients with T1DM aged less than 18 years assessed 
in London Middlesex County, Ontario. Screening methods in 
relation to recommended guidelines will be discussed.
Methods
The online survey was approved by the Ethics Review Board of 
Western University (#HSREB 104566). Questionnaires were 
distributed by e-mail to optometrists and ophthalmologists 
in London and Middlesex County listed in the Optometry 
Association of Ontario. This was conducted via Survey Monkey 
from February 10th, 2014 to March 1st, 2014.  Participants were 
advised that by opening the electronic survey and completing it, 
they were providing their consent to be involved in the study. 
Seven open-ended questions were administered to all 
participants Table 1. Questions on the survey were related to 
the frequency and technique of eye examinations routinely 
performed in T1D children. Responses were collected for 
review and analysis.
Results
Responses were received from 38 of 101 surveys sent 
(response rate 37.6%), which included 31 optometrists and 
7 ophthalmologists (81.6% and 18.4%, respectively). All 
responding optometrists and 6 out of 7 ophthalmologists 
examine children or adolescents aged less than 18 years with 
T1DM for DR. From the optometrist group, the majority (64.5 
%) examine less than 10 children and adolescents per year. 
From the ophthalmology group, the majority (57%) examine 
more than 10 patients per year.
Respondents use different methods to screen for DR as 
shown in Figure 1.  A subgroup of respondents (28%) examines 
for DR using multiple methods Figure 2. 
The majority of optometrists (96.8%) and ophthalmologists 
(71.4%) recommend annual eye exams for children and 
adolescents with T1DM if their exam is normal. One optometrist 
(3.2%) recommends exams every two years, and two 
ophthalmologists (28.6%) recommend exams every 6 months. 
In terms of referring patients for an ophthalmologist 
assessment, a higher percentage of optometrists (54.8%) 
refer those with signs of moderate non-proliferative diabetic 
retinopathy (NPDR). Two (6.5%) ophthalmologists refer with 
findings of mild NPDR and six (19.4%) refer only if evidence 
of severe NPDR.  19.3% refer children with T1DM only with 
evidence of proliferative diabetic retinopathy (either early or 
high risk). 
All ophthalmologists and 53% of optometrists send reports 
to both the family doctor and the endocrinologist; 38% of 
optometrists send reports to the family doctor only and 3% do 
not send any reports. 
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1. Do you assess patients with diabetes for diabetes retinopathy?      Y/N 
 
2. Do you exam children/adolescents aged less than 18 years with  
Type 1 diabetes?       Y/N 
 
3. Approximately, how many children/ adolescents aged less than 18 
years with type 1 diabetes do you exam per year?   
(Age groups: <5, 5-10, 10-15, 15-20) 
 
4. What is the method of screening used for the population with type 
1diabetes? 
a) Ophthalmoscopy without dilated fundi 
b) Ophthalmoscopy  on dilated fundi 
c) 7-field stereoscopic photography with pupil dilation  
d) 4-field wide-angle stereoscopic photography with pupil dilation 
e) Digital imaging (3-field) with no dilation 
f) Other method, please 
specify:_________________________________________________ 
 
5. If the eye exam is NORMAL, how frequently do you recommend eye 
exam for children and adolescents with type 1 diabetes? 
a) 6 months 
b) 12 months 
c) 24 months 
d) > 24 months 
 
6. If you are not an ophthalmologist, what abnormalities according to 
Airlie House classification for diabetic retinopathy do you refer children/
adolescents with type 1 diabetes to an ophthalmologist? 
a) Mild nonproliferative 
b) Moderate nonproliferative 
c) Severe nonproliferative 
d) Early proliferative retinopathy 
e) High risk proliferative retinopathy  
 
7. To whom do you send the eye examination reports? 
a) To Family doctor 
b) To Endocrinologist 
c) To both Family doctor and endocrinologist 
d) To family only 
e) Reports not sent 
Table 1. Eye Survey Questions
Figure 1. Methods for assessment of diabetic retinopathy (DR) used among 
children and adolescents with type 1 diabetes (T1DM).
Figure 2.  Distribution of multiple screening methods used in examining 
children and adolescents with type 1 diabetes (T1DM).
Discussion
Diabetic retinopathy rarely develops in children with Type 1 
diabetes <10 years of age regardless of the duration of diabetes.2 
In the Wisconsin Epidemiology Study of Diabetic Retinopathy 
4-year incidence study, no person <17 years of age developed 
proliferative retinopathy or macular edema.2 In the United 
Kingdom Prospective Diabetes Study (UKPDS), few patients 
without retinopathy at diagnosis of diabetes had disease 
progression to the point of requiring retinal photocoagulation 
(laser treatment) in the following 3 to 6 years.6
The Liverpool Diabetic Eye Study reported the 1-year 
cumulative incidence of sight-threatening diabetic retinopathy 
in individuals with Type 1 or Type 2 diabetes who, at baseline, 
had no diabetic retinopathy, had background retinopathy or 
had mild pre-proliferative retinopathy. In people with Type 
1 diabetes, the incidence in these groups was 0.3%, 3.6% and 
13.5%, respectively.7
In the pediatric population with Type 1 diabetes, others 
have  reported a decline in retinopathy supporting current 
guidelines that recommend lower glycemic targets and the use 
of intensive diabetes management  in children and adolescents 
with T1DM.3
In a cross-sectional study, Kubin et al (2011) examined the 
prevalence of DR through fundus photographs in children and 
adolescents diagnosed with T1DM. The overall prevalence of 
DR was 11.8% showing no decrease in the past 17 years.8
The largest prospective studies to date by Porta et al (2014) 
support the hypotheses that DR may appear later in patients 
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Screening Method Description Sensitivity Specificity
Methods done with pupil dilation
7-field stereoscopic 
photography
Film photographs of the retina taken at 30°-35° fields. Gold standard for documenting diabetic retinopathy as described in 
the Early Treatment Diabetic Retinopathy Study.12
4-field wide-angle 
stereoscopic photography
Digital coloured images of the retina taken at 45°-60° 
fields.13
94% for detecting severe 
NPDR or better
96% for detecting severe NPDR 
or better
Ophthalmoscopy with pupil 
dilation
Clinical examination of the retina using 
ophthalmoscope through dilated pupil.
65% (95% CI: 51-79%) 97% (95% CI: 95- 99%)
Fundus biomicroscopy Slit-lamp examination with use of biomicroscope to 
provide stereoscopic, highly magnified examination 
of the ocular fundus and vitreous with a large field 
of view. It should be considered the standard clinical 
technique for stereoscopic examination of the posterior 
pole of the eye.14
76% (95% CI: 70-81%) for 
detecting sight threatening DR
95% (95% CI: 95-96%) for 
detecting sight threatening DR
Methods done without pupil dilation
Ophthalmoscopy without 
pupil dilation
Clinical examination of the retina using 
ophthalmoscope without dilation of pupil.
Not available Not available
Digital imaging (3-field) 
without pupil dilation
Three 45° field stereoscopic fundus images obtained at 
the optic disc and macula, superotemporal to the optic 
disc, and nasal to the optic disc.15
98% 86%
Binocular indirect 
ophthalmoscopy (BIO)
Headband or Slit-lamp examination using a BIO lens. 
The slit lamp microscope binocular indirect method 
allows for assessment of the depth of retinal vascular 
lesions, disc evaluation and macular oedema. The 
head-band indirect
ophthalmoscopy method allows for views into the far 
periphery, past the equator.16
76% 95%
Optomap wide field image One stereoscopic digital image taken at up to 
200° (82%) of the retina, using scanning laser 
ophthalmoscope technology combined with a large 
ellipsoidal mirror.17
DR: 99% 
DR: 99% 
DR:
100%
PDR: 99%
CI, confidence interval
Table 2. Summary of screening methods for diabetic retinopathy
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who develop diabetes before puberty; however the long term 
pre-pubertal years add to its cumulative prevalence. DR is 
generally infrequent and mild during childhood and may be 
related to the shorter length of time of glycemic exposure.9
In terms of screening methods, ADA, CDA and IDF/ISPAD 
guidelines5,10,11 support fundus photography, with or without 
pupil dilation, as the method of screening for retinopathy. 
Nevertheless, ISPAD/IDF recognizes that this method may 
only be available in countries with ample resources, and thus it 
accepts dilated ophthalmoscopy as the minimum assessment.10 
CDA specifies 7-field stereoscopic fundal photography as the 
gold standard for DR screening.5  (Table 2)
Moreover, ISPAD/IDF advocates the onset of screening at 
age 11 years while CDA promotes later initiation of screening at 
15 years of age and after 5 years of diabetes duration.10 Table 3
This present survey highlights the lack of consistency both 
in the methods applied for retinopathy assessment as well as 
the time-intervals recommended by different specialists.
The divergent responses of this survey are a reflection of the 
different practices recommended by different expert groups. 
For example, ADA, CDA and ISPAD/IDF guidelines suggest 
annual DR screening, although there is no agreement on the age 
and duration of diabetes at initiation of screening.7  (Table 3)
In our survey, 94.7% of respondents, met the 
minimum recommendations and provided at least dilated 
ophthalmoscopy or fundal photography. Fundal photography 
was used by 34.2% of respondents, 9 respondents used 
it in combination with dilated ophthalmoscopy. Dilated 
ophthalmoscopy alone was used by 55.3%. 
Only less than 1% of our participants, all of whom were 
optometrists, apply the gold standard screening of 7-field 
fundal photography. Although it is not possible to confirm 
participant location, one explanation could be that these 
participants are linked to tertiary centres where higher 
resources are available.
The main limitation of this study is a low survey response rate 
which may not have captured the true prevalence of methods 
used for retinopathy screening and the communication gap 
between professionals.
Caring for children and adolescents with T1DM requires 
a multidisciplinary approach. Communication between 
healthcare members is crucial for optimal diabetes care 
and prevention of acute and chronic complications. CDA 
guidelines have no clear recommendations in relation to 
communication between specialists. ADA suggests that results 
of eye examinations should be documented and transmitted to 
Guideline 
recommendations
Initiate screening Frequency of screening Method of screening
ISPAD/IDF9-10 Start screening for retinopathy at age 
11 and after 2 years of type 1 diabetes 
duration. 
Screen annually after 2 to 5 years’ 
diabetes duration and more 
frequently if indicated.
For those with less than 10 
years of diabetes duration, with 
reasonable glycemic control 
may assess biennially by fundal 
photography.
Minimum retinopathy assessment should 
be by ophthalmoscopy through dilated 
pupils by an experienced observer. 
In countries with ample resources, 
retinopathy assessment should be by 
fundal photography with or without 
mydriasis.
CDA 20136 Start screening for retinopathy 5 years 
after type 1 diagnosis in all individuals 
15 years and older 
Five years after diagnosis of type 
1 diabetes in all individuals ≥15 
years, rescreen annually.
Seven-standard field, stereoscopic colour 
fundus photography with interpretation by 
a trained reader 
Direct  ophthalmoscopy or indirect slit-
lamp fundoscopy through dilated pupil, or
Digital fundus photography
ADA 201411 Consider initial dilated and 
comprehensive eye examination at 
start of puberty or at age 10, whichever 
is earlier, and after 5 years of type 1 
diabetes duration.
Annual screening. May increase to 
biennial eye exams if no findings 
on screening. 
If evidence of retinopathy is seen, 
then resume annual exams.
High-quality fundus photographs.
ISPAD, International Society of Pediatric and Adolescent Diabetes; IDF, International Diabetes Federation; CDA, Canadian Diabetes Association; ADA, American Diabetes Association.
Table 3. Summary of recommended guidelines for Diabetic Retinopathy screening
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the referring health care professional. Of note, almost 40% of 
optometrists in this survey report only to family doctors with 
no routine communication with the endocrinologist. Also, 3% 
of the participants do not report to any physician involved in 
the care of these children. 
In summary, this local survey demonstrated a broad range 
of screening methods for assessment of diabetic retinopathy 
with no consistency in relation to age of onset or frequency of 
eye examinations. It also identified a gap in communication 
between healthcare providers involved in the care of children 
and adolescents with T1DM. This highlights the need for 
improved communication in a timely manner in order to 
prevent the development of diabetes-related complications.
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